Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Prescribing Details for Zepbound A Zepbound prescription is viable for individuals with a BMI over 30 or a BMI over 27 with conditions like high blood pressure, heart disease, or type 2 diabetes
The SURMOUNT-1 trial found that participants without diabetes who took the highest dose of tirzepatide lost an average of 22.5% of body weight over 72 weeks, more than triple what most pre-GLP-1 interventions achieved
Often referred to as an eye stroke, NAION does not currently have effective treatment options
Payment does not guarantee a prescription
The GLP1 Bridge Program will give eligible Medicare beneficiaries temporary access to certain weightloss drugs
US$ 23.91
US$ 25.44
US$ 28.95
US$ 24.47
US$ 22.37
